338 related articles for article (PubMed ID: 4831456)
1. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
Schneider E; Fischer PA; Jacobi P
Med Klin; 1974 Mar; 69(13):541-5. PubMed ID: 4831456
[No Abstract] [Full Text] [Related]
2. [L-dopa therapy of Parkinson's syndrome. Comparison of pure L-dopa and the combination preparation L-dopa and decarboxylase inhibitor].
Görlich J; Markus E
Dtsch Med Wochenschr; 1972 Aug; 97(34):1246-8. PubMed ID: 5048316
[No Abstract] [Full Text] [Related]
3. L-dopa and amantadine hydrochloride in Parkinson's disease.
Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
[No Abstract] [Full Text] [Related]
4. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
Sigwald J; Raymondeaud C; Piot C
Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
[No Abstract] [Full Text] [Related]
5. [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].
Ferel D
Schweiz Med Wochenschr; 1972 Jan; 102(3):88-94. PubMed ID: 4551909
[No Abstract] [Full Text] [Related]
6. [Cardiovascular effects of L-dopa and decarboxylase inhibitor on patients with Parkinson's disease].
Desjacques P; Moret P; Gauthier G
Schweiz Med Wochenschr; 1973 Dec; 103(50):1783-5. PubMed ID: 4129257
[No Abstract] [Full Text] [Related]
7. [Treatment of Parkinson's syndrome with L-dopa and its methylated derivatives: 3-OMD and 4-OMD associated with a decarboxylase inhibitor. Clinical and biochemical study].
Tissot R; Bartholini G; Constantinidis J; Eisenring JJ; Geissbühler F; Yanniotis G; de Ajuriaguerra J
Schweiz Med Wochenschr; 1973 Oct; 103(42):1466-74. PubMed ID: 4750149
[No Abstract] [Full Text] [Related]
8. [Medical treatment of Parkinson's disease].
Castaigne P; Rondot P; Ribadeau-Dumas JL
Ann Med Interne (Paris); 1972 Apr; 123(4):357-64. PubMed ID: 5077040
[No Abstract] [Full Text] [Related]
9. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
Schwab RS; England AC
Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
[No Abstract] [Full Text] [Related]
10. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
Andrews CJ; Somerville B
Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384
[No Abstract] [Full Text] [Related]
11. [Combination therapy of Parkinson's syndrome using L-dopa and a decarboxylase inhibitor].
Fischer PA; Schneider E; Jacobi P; Maxion H
Med Welt; 1973 Nov; 24(45):1742-6. PubMed ID: 4768206
[No Abstract] [Full Text] [Related]
12. [Amantadine hydrochloride in the treatment of Parkinson's syndrome].
De la Herrán J; Figuerido JA
Rev Esp Otoneurooftalmol Neurocir; 1971; 29(167):45-9. PubMed ID: 5091472
[No Abstract] [Full Text] [Related]
13. [Problematic long-term therapy of Parkinson's syndrome using amantadine salts].
Diehl LW
Med Welt; 1975 Nov; 26(48):2188-91. PubMed ID: 813085
[No Abstract] [Full Text] [Related]
14. [Accomplishment of the treatment and evaluation of treatment alternatives in parkinsonism].
Presthus J
Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2119. PubMed ID: 4773985
[No Abstract] [Full Text] [Related]
15. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
Reveno WS; Bauer RB; Rosenbaum H
Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
[No Abstract] [Full Text] [Related]
16. [Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)].
Steinhäusl H
Wien Med Wochenschr; 1973 Jun; 123(26):433-5. PubMed ID: 4578743
[No Abstract] [Full Text] [Related]
17. [Present-day treatment of parkinsonism in the aged].
Siegfried J
Schweiz Rundsch Med Prax; 1973 Oct; 62(40):1202-3. PubMed ID: 4754539
[No Abstract] [Full Text] [Related]
18. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
Hacohen H; Gurtner B
Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377
[No Abstract] [Full Text] [Related]
19. [Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].
Stammler A; Vielhaber K
Fortschr Neurol Psychiatr Grenzgeb; 1972 Oct; 40(10):564-8. PubMed ID: 4565521
[No Abstract] [Full Text] [Related]
20. [Treatment of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor].
Lombardo L; de la Garza R; Ivan-Reynoso G
Arch Invest Med (Mex); 1974; 5(2):105-16. PubMed ID: 4433198
[No Abstract] [Full Text] [Related]
[Next] [New Search]